vs
Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and BRC Group Holdings, Inc. (RILY). Click either name above to swap in a different company.
BRC Group Holdings, Inc. is the larger business by last-quarter revenue ($188.3M vs $104.5M, roughly 1.8× Immunocore Holdings plc). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs -21.9%). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs -15.4%).
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.
IMCR vs RILY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $104.5M | $188.3M |
| Net Profit | — | $90.3M |
| Gross Margin | 97.4% | 79.5% |
| Operating Margin | -18.8% | 32.3% |
| Net Margin | — | 47.9% |
| Revenue YoY | 24.3% | -21.9% |
| Net Profit YoY | — | 1710.8% |
| EPS (diluted) | $-0.61 | $2.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $104.5M | $188.3M | ||
| Q3 25 | $103.7M | $215.3M | ||
| Q2 25 | $98.0M | $188.2M | ||
| Q1 25 | $93.9M | $197.2M | ||
| Q4 24 | $84.1M | $241.0M | ||
| Q3 24 | $80.2M | $225.5M | ||
| Q2 24 | $75.4M | $256.0M | ||
| Q1 24 | $70.5M | $263.4M |
| Q4 25 | — | $90.3M | ||
| Q3 25 | $-177.0K | $91.1M | ||
| Q2 25 | $-10.3M | $139.5M | ||
| Q1 25 | $5.0M | $-10.0M | ||
| Q4 24 | — | $-5.6M | ||
| Q3 24 | $8.7M | $-284.4M | ||
| Q2 24 | $-11.6M | $-433.6M | ||
| Q1 24 | $-24.4M | $-49.2M |
| Q4 25 | 97.4% | 79.5% | ||
| Q3 25 | 99.5% | 83.7% | ||
| Q2 25 | 98.9% | 81.3% | ||
| Q1 25 | 99.1% | 81.4% | ||
| Q4 24 | 99.6% | 79.8% | ||
| Q3 24 | 99.4% | 82.1% | ||
| Q2 24 | 97.7% | 84.5% | ||
| Q1 24 | 99.7% | 85.3% |
| Q4 25 | -18.8% | 32.3% | ||
| Q3 25 | -6.9% | 30.4% | ||
| Q2 25 | -15.2% | 5.7% | ||
| Q1 25 | -3.9% | -31.2% | ||
| Q4 24 | -23.1% | -69.2% | ||
| Q3 24 | -10.6% | -36.4% | ||
| Q2 24 | -21.2% | -90.8% | ||
| Q1 24 | -37.6% | -6.1% |
| Q4 25 | — | 47.9% | ||
| Q3 25 | -0.2% | 42.3% | ||
| Q2 25 | -10.5% | 74.1% | ||
| Q1 25 | 5.4% | -5.1% | ||
| Q4 24 | — | -2.3% | ||
| Q3 24 | 10.9% | -126.1% | ||
| Q2 24 | -15.4% | -169.4% | ||
| Q1 24 | -34.7% | -18.7% |
| Q4 25 | $-0.61 | $2.78 | ||
| Q3 25 | $0.00 | $2.91 | ||
| Q2 25 | $-0.20 | $4.50 | ||
| Q1 25 | $0.10 | $-0.39 | ||
| Q4 24 | $-0.47 | $-0.01 | ||
| Q3 24 | $0.17 | $-9.39 | ||
| Q2 24 | $-0.23 | $-14.35 | ||
| Q1 24 | $-0.49 | $-1.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $864.2M | $226.6M |
| Total DebtLower is stronger | — | $1.4B |
| Stockholders' EquityBook value | $381.0M | $-171.5M |
| Total Assets | $1.1B | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $864.2M | $226.6M | ||
| Q3 25 | $892.4M | $184.2M | ||
| Q2 25 | $882.8M | $267.4M | ||
| Q1 25 | $837.0M | $138.3M | ||
| Q4 24 | $820.4M | $146.9M | ||
| Q3 24 | $901.3M | $159.2M | ||
| Q2 24 | $859.6M | $236.9M | ||
| Q1 24 | $832.8M | $190.7M |
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | $438.7M | — | ||
| Q2 24 | $452.5M | — | ||
| Q1 24 | $452.5M | — |
| Q4 25 | $381.0M | $-171.5M | ||
| Q3 25 | $396.6M | $-260.5M | ||
| Q2 25 | $388.5M | $-351.7M | ||
| Q1 25 | $378.5M | $-496.8M | ||
| Q4 24 | $360.7M | $-488.2M | ||
| Q3 24 | $377.8M | $-497.6M | ||
| Q2 24 | $359.1M | $-218.3M | ||
| Q1 24 | $359.5M | $228.4M |
| Q4 25 | $1.1B | $1.7B | ||
| Q3 25 | $1.1B | $1.7B | ||
| Q2 25 | $1.1B | $1.5B | ||
| Q1 25 | $1.0B | $1.5B | ||
| Q4 24 | $1.0B | $1.8B | ||
| Q3 24 | $1.1B | $2.2B | ||
| Q2 24 | $1.0B | $3.2B | ||
| Q1 24 | $994.0M | $5.0B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.16× | — | ||
| Q2 24 | 1.26× | — | ||
| Q1 24 | 1.26× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-32.7M | $26.2M |
| Free Cash FlowOCF − Capex | $-35.5M | — |
| FCF MarginFCF / Revenue | -34.0% | — |
| Capex IntensityCapex / Revenue | 2.8% | — |
| Cash ConversionOCF / Net Profit | — | 0.29× |
| TTM Free Cash FlowTrailing 4 quarters | $-15.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-32.7M | $26.2M | ||
| Q3 25 | $-4.5M | $-60.6M | ||
| Q2 25 | $26.0M | $-25.6M | ||
| Q1 25 | $435.0K | $184.0K | ||
| Q4 24 | $-14.0M | $-2.7M | ||
| Q3 24 | $21.1M | $19.5M | ||
| Q2 24 | $23.5M | $111.5M | ||
| Q1 24 | $-4.6M | $135.4M |
| Q4 25 | $-35.5M | — | ||
| Q3 25 | $-5.2M | — | ||
| Q2 25 | $25.6M | — | ||
| Q1 25 | $137.0K | — | ||
| Q4 24 | $-17.5M | — | ||
| Q3 24 | $20.3M | — | ||
| Q2 24 | $23.1M | — | ||
| Q1 24 | $-5.0M | — |
| Q4 25 | -34.0% | — | ||
| Q3 25 | -5.0% | — | ||
| Q2 25 | 26.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | -20.9% | — | ||
| Q3 24 | 25.3% | — | ||
| Q2 24 | 30.7% | — | ||
| Q1 24 | -7.1% | — |
| Q4 25 | 2.8% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 4.3% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 0.6% | — |
| Q4 25 | — | 0.29× | ||
| Q3 25 | — | -0.66× | ||
| Q2 25 | — | -0.18× | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.42× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IMCR
Segment breakdown not available.
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
